:::

詳目顯示

回上一頁
題名:治療青春痘之運動禁藥Spironolactone
書刊名:大專體育
作者:劉汶璋許美智 引用關係
作者(外文):Liu, Wen-changHsu, Mei-chich
出版日期:2013
卷期:126
頁次:頁53-58
主題關鍵詞:治療用途豁免利尿劑女性運動員Therapeutic use exemptionDiureticsFemale athletes
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:3
  • 點閱點閱:50
spironolactone 為WADA 運動禁藥清單中S5 利尿劑及其他遮蔽劑之利尿劑成分,目前常用於治療痤瘡(即青春痘),極易造成運動員誤用的情形發生,運動員及運動相關人士應多瞭解此藥物以避免運動員誤用。spironolactone 因為具有「雄性賀爾蒙接受體阻斷劑」的作用,對於成人型痤瘡有良好治療效果,女性運動員容易發生誤用;現代利尿劑檢測技術日益精進,即使用量很少還是會被檢驗出陽性,所以在必要使用前治療用途豁免的賽前申請更顯得重要。
Spironolactone is one of the diuretics, which has been included in doping list S5 of diuretics and other masking agents of WADA. Athletes and sport stakeholders should learn more about doping to avoid misuse. Spironolactone is the blocker for androgenic hormone receptor and has been widely used for the acne (pimples) treatment in female. The chance of spironolactone misuse in female athletes is higher than that of male. Even very small quantities can be detected. Therefore, it is very important for athletes to apply Therapeutic Use Exemption before they use.
期刊論文
1.徐谷甫、許美智(20070600)。運動禁藥--芳香族酶抑制劑。大專體育,90,197-203。new window  延伸查詢new window
2.徐谷甫、蔡宗晏、林益安、曾玉華、黃瓊儀、韓毅雄、許美智(20110600)。運動員最常誤用禁藥之情形。大專體育學刊,13(2),215-221。new window  延伸查詢new window
3.陳亭亭、潘日南、許美智、倪戌江(20090400)。濫用藥物的檢驗分析及認證制度。警專學報,4(5),35-46。new window  延伸查詢new window
4.詹貴惠、許美智(19980600)。利尿劑對運動的影響。中華體育季刊,12(1)=45,102-109。new window  延伸查詢new window
5.Cadwallader, A. B.,、De la Torre, X.、Tieri, A.、Botrè, F.(2010)。The abuse of diuretics as performanceenhancing drugs and masking agents in sport doping: Pharmacology, toxicology and analysis。British Journal of Pharmacology,161(1),1-16。  new window
6.Haider, A.、Shaw, J. C.(2004)。Treatment of acne vulgaris。The Journal of The American Medical Association,292(6),726-735。  new window
7.Handelsman, D. J.、Heather, A.(2008)。Androgen abuse in sports。Asian Journal of Andrology,10(3),403-415。  new window
8.Olutunmbi, Y.、Paley, K.、English, J. C., Ⅲ(2008)。Adolescent female acne: Etiology and management。Journal of Pediatric and Adolescent Gynecology,21(4),171-176。  new window
9.Tan, J. K.、Ediriweera, C.(2010)。Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne。International Journal of Women’s Health,1,213-221。  new window
10.林益安、蔡宗晏、徐谷甫、曾玉華、黃瓊儀、陳志弘、許美智(20110300)。臺灣大專優秀選手藥品使用之現況。大專體育學刊,13(1),95-100。new window  延伸查詢new window
學位論文
1.陳美如(2010)。男性大學生的中醫體質與痤瘡之關係(碩士論文)。南華大學。  延伸查詢new window
圖書
1.許美智、詹貴惠(2012)。運動藥物學。高雄市:春橋田。  延伸查詢new window
其他
1.World Anti-Doping Agency(2004)。World anti-doping agency,http://www.wadaama.org,(Technical document-TD2004MRPL (2004))。 2010/10/15。  new window
2.World Anti-Doping Agency(2009)。World anti-doping agency,http://www.wadaama.org,(Technical document-TD2009MRPL (2009a))。 2010/10/15。  new window
3.World Anti-Doping Agency(2010)。World anti-doping agency,http://www.wadaama.org,(Technical document-TD2010MRPL (2010))。 2010/10/15。  new window
4.World Anti-Doping Agency(2012)。World anti-doping agency,http://www.wadaama.org,(Technical documen-TD2012MRPL (2012))。 2012/10/15。  new window
5.World Anti-Doping Agency(2013)。World anti-doping agency,http://www.wadaama.org,(Technical document-TD2013MRPL (2013))。 2013/01/15。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE